Persistent pain, sensory disturbances and functional impairment after adjuvant chemotherapy for breast cancer: Cyclophosphamide, epirubicin and fluorouracil compared with docetaxel + epirubicin and cyclophosphamide

TAXTOX – a retrospective study regarding the side effects of docetaxel given as part of the adjuvant treatment to patients with primary breast cancer in Denmark from 2007 to 2009

(2011) Lise Eckhoff et al.   ACTA ONCOLOGICA

Persistent pain after targeted intraoperative radiotherapy (TARGIT) or external breast radiotherapy for breast cancer: A randomized trial

(2011) Kenneth Geving Andersen et al.   BREAST

Chemotherapy-induced peripheral neuropathies: from clinical relevance to preclinical evidence

(2011) David Balayssac et al.   Expert Opinion On Drug Safety

Persistent Pain After Breast Cancer Treatment: A Critical Review of Risk Factors and Strategies for Prevention

(2011) Kenneth Geving Andersen et al.   JOURNAL OF PAIN

Self-reported arm-lymphedema and functional impairment after breast cancer treatment – A nationwide study of prevalence and associated factors

(2010) Rune Gärtner et al.   BREAST

Association between patient reported outcomes and quantitative sensory tests for measuring long-term neurotoxicity in breast cancer survivors treated with adjuvant paclitaxel chemotherapy

(2010) Dawn L. Hershman et al.   BREAST CANCER RESEARCH AND TREATMENT

Adjuvant Docetaxel for High-Risk, Node-Negative Breast Cancer

(2010) Miguel Martín et al.   NEW ENGLAND JOURNAL OF MEDICINE

Prevalence of and Factors Associated With Persistent Pain Following Breast Cancer Surgery

(2009) Rune Gärtner et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Danish Breast Cancer Cooperative Group – DBCG: History, organization, and status of scientific achievements at 30-year anniversary

(2008) Mogens Blichert-Toft et al.   ACTA ONCOLOGICA

The clinical database and the treatment guidelines of the Danish Breast Cancer Cooperative Group (DBCG); its 30-years experience and future promise

(2008) Susanne Møller et al.   ACTA ONCOLOGICA

Mechanisms Underlying Chemotherapy-Induced Neurotoxicity and the Potential for Neuroprotective Strategies

(2008) S. Park et al.   CURRENT MEDICINAL CHEMISTRY

Taxane-Based Combinations As Adjuvant Chemotherapy of Early Breast Cancer: A Meta-Analysis of Randomized Trials

(2007) Michele De Laurentiis et al.   JOURNAL OF CLINICAL ONCOLOGY